Proficio Capital Partners LLC bought a new stake in shares of Arteris, Inc. (NASDAQ:AIP - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 44,123 shares of the company's stock, valued at approximately $450,000. Proficio Capital Partners LLC owned about 0.11% of Arteris as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. US Bancorp DE acquired a new stake in shares of Arteris in the third quarter worth $34,000. R Squared Ltd acquired a new stake in shares of Arteris in the fourth quarter worth $64,000. MetLife Investment Management LLC increased its stake in shares of Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company's stock worth $131,000 after acquiring an additional 9,551 shares during the period. SG Americas Securities LLC acquired a new stake in shares of Arteris in the fourth quarter worth $134,000. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in shares of Arteris in the third quarter worth $226,000. Hedge funds and other institutional investors own 64.36% of the company's stock.
Insiders Place Their Bets
In other Arteris news, VP Paul L. Alpern sold 3,326 shares of Arteris stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $12.35, for a total transaction of $41,076.10. Following the transaction, the vice president now directly owns 61,604 shares of the company's stock, valued at $760,809.40. The trade was a 5.12 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Nicholas B. Hawkins sold 5,968 shares of Arteris stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $8.57, for a total transaction of $51,145.76. Following the sale, the chief financial officer now owns 186,123 shares of the company's stock, valued at approximately $1,595,074.11. This represents a 3.11 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 330,305 shares of company stock valued at $3,471,358 over the last ninety days. Company insiders own 33.70% of the company's stock.
Analyst Upgrades and Downgrades
AIP has been the topic of a number of research reports. Rosenblatt Securities reiterated a "buy" rating and issued a $15.00 price objective on shares of Arteris in a research note on Tuesday, February 18th. Northland Securities raised their price target on shares of Arteris from $14.00 to $16.00 and gave the company an "outperform" rating in a research report on Wednesday, February 19th.
Check Out Our Latest Research Report on Arteris
Arteris Price Performance
AIP traded up $0.17 during midday trading on Friday, hitting $7.63. 80,681 shares of the company traded hands, compared to its average volume of 193,236. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.30. The company has a market capitalization of $312.43 million, a price-to-earnings ratio of -8.77 and a beta of 1.21. Arteris, Inc. has a 52-week low of $5.76 and a 52-week high of $12.64. The business has a 50 day simple moving average of $10.04 and a two-hundred day simple moving average of $8.81.
Arteris (NASDAQ:AIP - Get Free Report) last posted its quarterly earnings results on Tuesday, February 18th. The company reported ($0.19) earnings per share for the quarter, missing the consensus estimate of ($0.11) by ($0.08). The business had revenue of $15.49 million during the quarter, compared to analysts' expectations of $15.34 million. Arteris had a negative return on equity of 828.71% and a negative net margin of 58.27%. On average, equities analysts forecast that Arteris, Inc. will post -0.73 earnings per share for the current fiscal year.
Arteris Company Profile
(
Free Report)
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading

Before you consider Arteris, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Arteris wasn't on the list.
While Arteris currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.